{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:19:16Z","timestamp":1745381956920,"version":"3.40.4"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To describe effects of sustained-release steroid delivery devices on intraocular pressure (IOP) in eyes with glaucoma drainage devices.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Retrospective case series of eyes with steroid implants (dexamethasone or fluocinolone acetonide) and prior glaucoma drainage devices (Ahmed, Baerveldt) without uveitis. Outcomes included IOP, IOP rise, central foveal thickness, and IOP medications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We included 14 eyes (14 patients, 38% men, 94% pseudophakic). Mean age at steroid implantation was 64 \u00b1 12 years. Baerveldt (64%) was more common than Ahmed (36%). Tubes were in the anterior chamber (57.1%), sulcus (28.6%), and pars plana (14.3%). Ozurdex (93%) was more common than Yutiq (7%). Mean IOP was 13.5 \u00b1 3.4 mmHg preimplant, 11.8 \u00b1 3.7 mmHg at month 1, 13.3 \u00b1 3.6 mmHg at month 3 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.35), and 11.3 \u00b1 3.8 mmHg at 1 year (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.032). Mean antihypertensive medication was unchanged at month 3 (<jats:italic toggle=\"yes\">P<\/jats:italic> = 1.0) and \u22120.36 medication at last follow-up (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.35). Mean central foveal thickness change was \u2212204 \u00b1 158 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). There were no cases of endophthalmitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intravitreal steroid implants were safe and effective for the treatment of postsurgical CME in patients with pre-existing glaucoma drainage devices. There was no increase in IOP and no increase in antihypertensive drops.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004396","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:00:06Z","timestamp":1736809206000},"page":"877-882","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["INTRAVITREAL SUSTAINED RELEASE STEROID IMPLANTS ARE SAFE AND EFFECTIVE IN PATIENTS WITH GLAUCOMA DRAINAGE DEVICES"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4060-8187","authenticated-orcid":false,"given":"Henry W.","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Tandias","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward S.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Sol\u00e1-Del","family":"Valle","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"},{"name":"Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Carle Illinois College of Medicine, Chittick Eye Care, Champaign, Illinois."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-6104","authenticated-orcid":false,"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250422","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: a review of the literature","volume":"20","author":"Kersey","year":"2006","journal-title":"Eye (Lond)"},{"key":"R2-20250422","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"key":"R3-20250422","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ophtha.2022.01.015","article-title":"Three-year safety and efficacy of the 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: the PALADIN study","volume":"129","author":"Singer","year":"2022","journal-title":"Ophthalmology"},{"key":"R4-20250422","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.oret.2023.08.004","article-title":"The 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: intraocular pressure-related effects over 36 months","volume":"8","author":"Roth","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"R5-20250422","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"R6-20250422","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajo.2009.12.009","article-title":"Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma","volume":"149","author":"Malone","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R7-20250422","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/IJG.0000000000001454","article-title":"Combined dexamethasone intravitreal implant and glaucoma drainage device placement for uveitic glaucoma","volume":"29","author":"Nguyen","year":"2020","journal-title":"J Glaucoma"},{"key":"R8-20250422","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ogla.2021.08.007","article-title":"Effects of postoperative intravitreal injections on outcomes of traditional glaucoma surgery in patients with preoperative intravitreal injections","volume":"5","author":"Chang","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"R9-20250422","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.3390\/ijms24119591","article-title":"Current treatments for diabetic macular edema","volume":"24","author":"Tatsumi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R10-20250422","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archopht.125.3.309","article-title":"Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema","volume":"125","author":"Kuppermann","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R11-20250422","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00417-024-06468-z","article-title":"Changes in intraocular pressure following intravitreal dexamethasone implant in patients with history of glaucoma filtration surgery","volume":"262","author":"Lee","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:00:46Z","timestamp":1745352046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004396","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}